Latest Molecular imaging Stories
A new MRI method to map creatine at higher resolutions in the heart may help clinicians and scientists find abnormalities and disorders earlier than traditional diagnostic methods
NEWPORT NEWS, Va., Jan. 6, 2014 /PRNewswire/ -- Dilon Technologies Inc.
The Pre-clinical imaging market is highly competitive, with each player vying to make a mark and gain a large market share.
The global market for molecular imaging devices was valued at $2 billion in 2012 and is expected to reach $2.2 billion in 2013.
- A hairdresser.